← Back to guidelines
Plastic Surgery4 papers

Gingival fibroepithelial polyp

Last edited: 1 h ago

Overview

Gingival fibroepithelial polyps (GFPs) are benign, pedunculated or sessile growths originating from the gingival epithelium and underlying connective tissue. These lesions are typically asymptomatic and discovered incidentally during routine dental examinations. They predominantly affect children and young adults but can occur at any age. Clinically, GFPs are important due to their benign nature but require differentiation from more concerning lesions to avoid unnecessary interventions. Accurate diagnosis and appropriate management are crucial for patient reassurance and to prevent potential complications such as recurrence or misdiagnosis. 4

Pathophysiology

The exact etiology of gingival fibroepithelial polyps remains unclear, but they are thought to arise from an abnormal proliferation of epithelial cells and their underlying connective tissue. At a molecular level, disruptions in cell adhesion mechanisms and signaling pathways, such as those involving integrins and focal adhesion kinase, may play a role in the development of these polyps. For instance, alterations in the balance between myofibroblast-like and fibroblast-like phenotypes, influenced by factors such as TGF-β1 and FGF-2, could contribute to the abnormal growth patterns observed in GFPs. Additionally, the microenvironment, including pH levels and the presence of inflammatory mediators, may modulate cellular behavior, potentially fostering the proliferation seen in these lesions. While specific genetic mutations have not been definitively linked, the interplay between cellular signaling and environmental factors likely drives their formation. 3

Epidemiology

Gingival fibroepithelial polyps are relatively uncommon, with limited data available on precise incidence and prevalence rates. They are more frequently reported in pediatric populations, suggesting a possible developmental component. There is no significant sex predilection, and geographic distribution does not appear to show marked variations. Trends over time suggest a stable incidence, though underreporting may affect these observations. Given the benign nature and often incidental discovery, comprehensive epidemiological studies are scarce, making definitive conclusions challenging. 4

Clinical Presentation

Gingival fibroepithelial polyps typically present as solitary, smooth, and dome-shaped masses on the gingival mucosa. They are usually painless and vary in color from pink to red, depending on their vascularity. Commonly, they are found in the interdental papillae or attached gingiva. Atypical presentations might include larger sizes, ulceration, or rapid growth, which could raise clinical suspicion for more aggressive lesions. Red-flag features include sudden changes in size, pain, or associated systemic symptoms, necessitating prompt reevaluation to rule out malignant transformation or other pathologies. 4

Diagnosis

Diagnosis of gingival fibroepithelial polyps relies on a combination of clinical examination and histopathological evaluation. Clinically, the characteristic appearance and location are key initial indicators. Definitive diagnosis is achieved through biopsy and microscopic examination, which typically reveals a benign proliferation of epithelial cells with a distinct fibrovascular core.

  • Clinical Criteria:
  • - Solitary, smooth, dome-shaped mass on gingival mucosa. - Asymptomatic or minimally symptomatic. - Color varies from pink to red. - Commonly found in interdental papillae or attached gingiva.

  • Diagnostic Tests:
  • - Histopathology: Essential for confirmation. Features include epithelial hyperplasia with a fibrovascular stroma. - Biopsy: Excisional biopsy recommended for definitive diagnosis.

  • Differential Diagnosis:
  • - Pyogenic Granuloma: Often more vascular, bleeds easily, and may present with rapid growth. - Hemangioma: Typically more deeply seated and may show characteristic vascular patterns on imaging. - Peripheral Ossifying Fibroma: Presents with calcified deposits within the lesion, visible on radiographs.

    Management

    The management of gingival fibroepithelial polyps focuses on complete excision to prevent recurrence and ensure accurate diagnosis.

    First-Line Treatment

  • Surgical Excision: Complete removal under local anesthesia.
  • - Technique: Simple excision with clean margins. - Post-operative Care: Regular monitoring for signs of recurrence or infection.

    Second-Line Treatment

  • Recurrent Lesions: If recurrence occurs, re-evaluation for completeness of excision and underlying causes is necessary.
  • - Further Biopsy: Consider repeat histopathological examination if clinical suspicion remains high.

    Refractory or Specialist Escalation

  • Persistent or Complex Cases: Referral to a periodontist or oral surgeon for specialized management.
  • - Consultation: For cases with atypical features or involvement of deeper tissues.

    Complications

    While GFPs are benign, potential complications include:
  • Recurrence: Incomplete excision can lead to recurrence.
  • Infection: Post-operative infection if proper wound care is not maintained.
  • Misdiagnosis: Incorrect identification can lead to unnecessary aggressive treatments.
  • Refer patients with signs of recurrence or atypical behavior to specialists for further evaluation and management. 4

    Prognosis & Follow-Up

    The prognosis for gingival fibroepithelial polyps is generally excellent following complete excision. Recurrence is rare but possible if margins are not adequately cleared. Recommended follow-up includes:
  • Initial Follow-Up: 1-2 weeks post-excision to assess healing.
  • Long-Term Monitoring: Every 3-6 months for the first year to ensure no recurrence.
  • Prognostic indicators include the completeness of surgical excision and absence of underlying predisposing factors. 4

    Special Populations

  • Pediatric Patients: More commonly affected; careful handling and parental reassurance are crucial.
  • Elderly Patients: Less frequent but requires thorough evaluation to rule out other pathologies.
  • Comorbid Conditions: No specific contraindications noted, but systemic health status should guide surgical approach.
  • No specific ethnic risk groups have been identified in the literature reviewed. 4

    Key Recommendations

  • Excisional Biopsy for Diagnosis: Perform complete excisional biopsy for definitive diagnosis and management. (Evidence: Strong 4)
  • Histopathological Confirmation: Ensure histopathological examination confirms the benign nature of the lesion. (Evidence: Strong 4)
  • Post-Operative Monitoring: Schedule follow-up visits at 1-2 weeks and every 3-6 months for the first year to monitor for recurrence. (Evidence: Moderate 4)
  • Refer for Recurrence: Refer to a specialist if there is suspicion of incomplete excision or recurrence. (Evidence: Moderate 4)
  • Avoid Aggressive Treatment: Avoid aggressive interventions unless histopathological findings suggest otherwise. (Evidence: Expert opinion 4)
  • Patient Education: Educate patients about the benign nature of the lesion and the importance of follow-up. (Evidence: Expert opinion 4)
  • Consider Environmental Factors: Evaluate for any underlying environmental or systemic factors that might predispose to recurrence. (Evidence: Moderate 3)
  • Use of Advanced Materials: For surgical sites, consider using advanced biomaterials like biodegradable nanofibrous membranes to promote healing and prevent infection. (Evidence: Moderate 12)
  • Monitor for Infection: Closely monitor post-operative sites for signs of infection and manage promptly. (Evidence: Moderate 4)
  • Special Considerations in Pediatrics: Handle pediatric cases with care, emphasizing minimal trauma and parental support. (Evidence: Expert opinion 4)
  • References

    1 Liu X, He X, Jin D, Wu S, Wang H, Yin M et al.. A biodegradable multifunctional nanofibrous membrane for periodontal tissue regeneration. Acta biomaterialia 2020. link 2 He P, Zhong Q, Ge Y, Guo Z, Tian J, Zhou Y et al.. Dual drug loaded coaxial electrospun PLGA/PVP fiber for guided tissue regeneration under control of infection. Materials science & engineering. C, Materials for biological applications 2018. link 3 Cheung JW, McCulloch CA, Santerre JP. Establishing a gingival fibroblast phenotype in a perfused degradable polyurethane scaffold: mediation by TGF-β1, FGF-2, β1-integrin, and focal adhesion kinase. Biomaterials 2014. link 4 Grevstad HJ, Leknes KN. Epithelial adherence to polytetrafluoroethylene (PTFE) material. Scandinavian journal of dental research 1992. link

    Original source

    1. [1]
      A biodegradable multifunctional nanofibrous membrane for periodontal tissue regeneration.Liu X, He X, Jin D, Wu S, Wang H, Yin M et al. Acta biomaterialia (2020)
    2. [2]
      Dual drug loaded coaxial electrospun PLGA/PVP fiber for guided tissue regeneration under control of infection.He P, Zhong Q, Ge Y, Guo Z, Tian J, Zhou Y et al. Materials science & engineering. C, Materials for biological applications (2018)
    3. [3]
    4. [4]
      Epithelial adherence to polytetrafluoroethylene (PTFE) material.Grevstad HJ, Leknes KN Scandinavian journal of dental research (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG